Australia, Oct. 7 -- iOmx Therapeutics AG, owns the trademark (2532098) for 'IOMX' till Dec. 18, 2034.
Status: protected:
Registered/protected
Classes: 1 [Chemical preparations for scientific and industrial purposes; genetically engineered polypeptides and proteins, in particular antibodies and antibody-like polypeptides and proteins, and nucleic acid coding for these, in particular artificial polypeptides and proteins and nucleic acid coding for these; diagnostic preparations, except for medical or veterinary use.], 5 [Pharmaceuticals, medical and veterinary preparations; pharmaceutical preparations and formulations and medicinal health preparations for use in the treatment or prevention of diseases, ailments and/or disorders in humans a...